What's the difference between NewDoc and Medmate?
NewDoc bulk-bills the consultation at $0 for eligible Medicare cardholders, with the eScript, mental health care plan, and any same-visit referral or certificate included. Per Medmate's public site, Medmate is private-pay per product: telehealth consultation $49, online prescription $25, medical certificate from $19.90, and blood test $25.
Medmate's main point of difference is a bundled online pharmacy with medication delivery, and a stated 24/7 window. NewDoc's is a $0 bulk-billed consultation with FRACGP-qualified GPs and an eScript you can fill at any pharmacy.
NewDoc vs Medmate at a glance
NewDoc and Medmate are both Australian telehealth services that consult by phone or video. The structural difference is how you pay and what is bundled. Medmate charges a separate fee for each product and pairs the consultation with its own pharmacy delivery. NewDoc bills the consultation to Medicare, so eligible cardholders pay $0 out of pocket, and sends an eScript you can fill at any pharmacy.
The table below compares the two on the dimensions that drive cost and experience. Comparison data verified as at 6 June 2026.
| Dimension | NewDoc | Medmate |
|---|---|---|
| Pricing model | Bulk-billed Medicare consult | Per-product fee |
| Lowest listed price | $0 (Medicare) | From $19.90 (medical certificate) |
| Bulk-billed? | Yes | No |
| Doctor type | FRACGP-qualified GPs only | AHPRA-registered doctors and nurse practitioners |
| Same-day availability | Yes | Yes (24/7) |
| Mental health care plan | Yes (bulk-billed) | Not publicly listed |
| Referrals | Yes (included in consult) | Pathology / blood tests from $25; specialist referrals not separately listed |
Comparison data verified as at 6 June 2026. Values reflect each provider's lowest publicly listed pricing or stated feature on their own website. Prices and features change — check Medmate directly for current information before booking. "Bulk-billed" = no out-of-pocket cost for eligible Medicare cardholders.
When NewDoc fits
NewDoc's bulk-billed model is structurally cheaper for any Medicare-eligible patient. Choose NewDoc if any of the following apply:
- You are eligible for Medicare and want $0 out-of-pocket for the consultation and any documents issued.
- You want a FRACGP-qualified Australian-trained general practitioner specifically.
- You need a mental health care plan included in the bulk-billed consultation.
- You are happy to fill your eScript at any pharmacy rather than through one bundled delivery service.
- You need ongoing care and want every review consultation and script repeat bulk-billed.
When Medmate might fit
Medmate may suit a specific need. Choose Medmate if any of the following apply:
- You want the consultation and medication delivery bundled through one service rather than filling a script yourself.
- You need care overnight, where Medmate's stated 24/7 window is wider than NewDoc's daytime and evening hours.
- You are not Medicare-eligible and are comparing private per-product telehealth fees.
Worked example: a single multi-need visit
Consider a Medicare-eligible patient who needs a consultation, a repeat script, and a medical certificate from one visit. On the publicly listed prices as at 6 June 2026:
- NewDoc: $0. One bulk-billed consultation covers the visit, the eScript, and the certificate.
- Medmate: telehealth consultation $49, online prescription $25, and medical certificate from $19.90, charged per product, for roughly $93.90 before any delivery fee.
For a single low-cost item such as a short certificate (from $19.90), Medmate can be competitive. The bulk-billed model pulls ahead as soon as a visit needs a consultation or more than one document.
Verify both before booking
Pricing and features change. Every claim above was verified against each provider's public website as at 6 June 2026. Before you book, confirm current pricing on NewDoc's pricing page and check Medmate's own site directly. For a wider comparison across all major Australian online doctor services, see our hub comparison.
Last reviewed 6 June 2026. Editorial policy